Medical technology company RaySearch Laboratories AB (STO:RAYB) announced on Monday that Clínica El Rosario in Colombia has become the first RaySearch customer in South America to go live with the treatment planning system RayStation for Accuray's Radixact System.
According to the company, the installation comprises clinical-class capabilities for 3D conformal planning, IMRT, physician review and contouring, multi-criteria optimisation, auto breast planning, fallback and electron planning, as well as deformable registration. RayStation supports planning for Accuray's Radixact System, the treatment planning software which was developed in partnership with Accuray.
Reportedly, this project was made possible with the support of Rocol S.A, a Colombian company with headquarters in Barranquilla, and strategic partner of RaySearch in the region. Clínica El Rosario went live with RayStation for Radixact planning in January 2020.
Also, the clinic has ordered the company's oncology information system RayCare. The combination of RayStation and RayCare is expected to offer significant efficiency gains and advanced features to the clinic.
RaySearch, a developer of software solutions to improve cancer care, markets the RayStation treatment planning system and RayCare, the next-generation oncology information system, worldwide.
Scancell initiates SCOPE trial's iSCIB1+ cohort
Bio-Thera Solutions' BAT8006 phase II Study receives US FDA IND approval
Poseida Therapeutics names new chief medical officer
Biocytogen and ABL Bio collaborate on development of new bispecific antibody-drug conjugates
BioVaxys Technology announces non-brokered private placement
Senhwa Biosciences doses first subject in phase II study of Silmitasertib
Antennova completes first dosing cohort in Phase one study of ATN-031
M8 Pharmaceuticals collaborates with SERB Pharmaceuticals
BerGenBio ASA starts Phase 2a portion of BGBC016 clinical study of bemcentinib
Phanes Therapeutics receives FDA Fast Track designation for PT886